Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy

Thyroid

Volumn 18, Issue 12, 2008, Pages 1291-1296

  Khoo, Teck Kim ^a   Coenen, Michael J ^a   Schiefer, A Reagan ^a   Kumar, Seema ^a   Bahn, Rebecca S ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; THY 1 ANTIGEN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DECOMPRESSION SURGERY; ENDOCRINE OPHTHALMOPATHY; EUTHYROIDISM; FEMALE; FIBROBLAST CULTURE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MALE; ORBIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ADULT; ANIMALS; ANTIGENS, THY-1; CONNECTIVE TISSUE; FEMALE; FIBROBLASTS; GENE EXPRESSION; GRAVES OPHTHALMOPATHY; HUMANS; MALE; MICE; MIDDLE AGED; ORBIT; RNA, MESSENGER;

EID: 57449105086     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0255     Document Type: Article

References (13)

1. Bahn RS 2003 Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 88:1939-1946.
2. Garrity JA, Bahn RS 2006 Pathogenesis of Graves' ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol 142:147-153.
3. Prabhakar BS, Bahn RS, Smith TJ 2003 Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 24:802-835.
4. Rege TA, Hagood JS 2006 Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J 20:1045-1054.
5. Haeryfar SMM, Hoskin DW 2004 Thy-1: more than a mouse pan-T cell marker. J Immunol 173:3581-3588.
6. Koumas L, Smith TJ, Feldon S, Blumberg N, Phipps RP 2003 Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. J Pathol 163:1291-1300.
7. Koumas L, Smith TJ, Phipps RP 2002 Fibroblast subsets in the human orbit: Thy-1+ and Thy-1 - subpopulations exhibit distinct phenotypes. Eur J Immunol 32:477-485.
8. Borrello MA, Phipps RP 1996 Differential Thy-1 expression by splenic fibroblasts defines functionally distinct subsets. Cell Immunol 173:198-206.
9. Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP, Sorisky A 2002 Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 87:385-392.
10. Kumar S, Leontovich A, Coenen MJ, Bahn RS 2005 Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis. J Clin Endocrinol Metab 90:4730-4735.
11. Kumar S, Coenen MJ, Scherer PE, Bahn RS 2004 Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 89:930-935.
12. Kumar S, Bahn RS 2003 Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 88:4246-4250.
13. Hagood JS, Prabhakaran P, Kumbla P, Salazar L, MacEwen MW, Barker TH, Ortiz LA, Schoeb T, Siegal GP, Alexander CB, Pardo A, Selman M 2005 Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol 167:365-379.